ATE104853T1 - Verwendung des 6-((3-(4-(2-methoxyphenyl)-1piperazinyl>propyl>amino>-1,3-dimethyluracils zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von harnwegsverstopfungen. - Google Patents

Verwendung des 6-((3-(4-(2-methoxyphenyl)-1piperazinyl>propyl>amino>-1,3-dimethyluracils zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von harnwegsverstopfungen.

Info

Publication number: ATE104853T1
Authority: AT; Austria
Prior art keywords: dimethyluracil; methoxyphenyl; propyl; amino; manufacture
Prior art date: 1989-09-06

Application number

AT9090309607T

Other languages

English (en)

Inventor

Masayuki Ishikawa

Hiroshi Azuma

Shigeru Ito

Tomohiro Yamaguchi

Original Assignee

Hitachi Chemical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-06

Filing date

1990-09-03

Publication date

1994-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16912699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE104853(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-09-03 Application filed by Hitachi Chemical Co Ltd filed Critical Hitachi Chemical Co Ltd

1994-05-15 Application granted granted Critical

1994-05-15 Publication of ATE104853T1 publication Critical patent/ATE104853T1/de

Links

OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
210000001635 urinary tract Anatomy 0.000 title 1
ICMGLRUYEQNHPF-UHFFFAOYSA-N Uraprene Chemical compound COC1=CC=CC=C1N1CCN(CCCNC=2N(C(=O)N(C)C(=O)C=2)C)CC1 ICMGLRUYEQNHPF-UHFFFAOYSA-N 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
201000002327 urinary tract obstruction Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT9090309607T 1989-09-06 1990-09-03 Verwendung des 6-((3-(4-(2-methoxyphenyl)-1piperazinyl>propyl>amino>-1,3-dimethyluracils zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von harnwegsverstopfungen. ATE104853T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP23075089		1989-09-06

Publications (1)

Publication Number	Publication Date
ATE104853T1 true ATE104853T1 (de)	1994-05-15

Family

ID=16912699

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT9090309607T ATE104853T1 (de)	1989-09-06	1990-09-03	Verwendung des 6-((3-(4-(2-methoxyphenyl)-1piperazinyl>propyl>amino>-1,3-dimethyluracils zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von harnwegsverstopfungen.

Country Status (8)

Country	Link
US (1)	US5145851A (de)
EP (1)	EP0416841B1 (de)
JP (1)	JPH078795B2 (de)
KR (1)	KR930001808B1 (de)
AT (1)	ATE104853T1 (de)
CA (1)	CA2024428A1 (de)
DE (1)	DE69008466T2 (de)
DK (1)	DK0416841T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2693195B1 (fr) *	1992-07-03	1994-09-23	Synthelabo	Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
ATE123025T1 (de) *	1992-07-03	1995-06-15	Synthelabo	2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
DE69314399T3 (de) *	1992-07-23	2001-08-09	Aisin Aw Co., Ltd.	Lautstärkeregelung für ein akustisches Leitungsgerät für Fahrzeuge
FR2701260B1 (fr) *	1993-02-05	1995-05-05	Esteve Labor Dr	Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
DE19514579A1 (de)	1995-04-20	1996-10-24	Boehringer Ingelheim Kg	Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
IT1293804B1 (it) *	1997-08-01	1999-03-10	Recordati Chem Pharm	Diarilalchilpiperazine attive sulle basse vie urinarie
EP1273572B9 (de) *	1997-10-09	2005-03-02	Ortho-McNeil Pharmaceutical, Inc.	Mit Thiophen substituierte Piperazine für die Behandlung von benigner Prostatahyperplasie
AU2003204320B2 (en) *	1997-10-09	2006-01-19	Ortho-Mcneil Pharmaceutical, Inc.	Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
ATE284869T1 (de) *	1997-10-09	2005-01-15	Ortho Mcneil Pharm Inc	Mit thiophen substituierte piperazine für die behandlung von benigner prostatahyperplasie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE755015A (fr) *	1969-08-20	1971-02-01	Byk Gulden Lomberg Chem Fab	Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation
JPS6140229A (ja) *	1984-07-19	1986-02-26	イー・アイ・デユポン・デ・ニモアス・アンド・カンパニー	２，３‐ジクロロブタンから２‐クロロブテンを製造する方法
JPS6426517A (en) *	1987-07-21	1989-01-27	Sankyo Co	Remedy for dysuria

1990
- 1990-08-31 CA CA002024428A patent/CA2024428A1/en not_active Abandoned
- 1990-08-31 JP JP2232057A patent/JPH078795B2/ja not_active Expired - Lifetime
- 1990-09-03 DK DK90309607.1T patent/DK0416841T3/da active
- 1990-09-03 AT AT9090309607T patent/ATE104853T1/de not_active IP Right Cessation
- 1990-09-03 DE DE69008466T patent/DE69008466T2/de not_active Expired - Fee Related
- 1990-09-03 EP EP90309607A patent/EP0416841B1/de not_active Revoked
- 1990-09-06 KR KR1019900014074A patent/KR930001808B1/ko not_active Expired - Fee Related
1991
- 1991-10-17 US US07/780,405 patent/US5145851A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US5145851A (en)	1992-09-08
CA2024428A1 (en)	1991-03-07
DE69008466T2 (de)	1994-08-18
DE69008466D1 (de)	1994-06-01
JPH078795B2 (ja)	1995-02-01
KR910005867A (ko)	1991-04-27
JPH03173819A (ja)	1991-07-29
EP0416841B1 (de)	1994-04-27
EP0416841A3 (en)	1991-10-23
DK0416841T3 (da)	1994-05-24
EP0416841A2 (de)	1991-03-13
KR930001808B1 (ko)	1993-03-13

Similar Documents

Publication	Publication Date	Title
DE60024854D1 (de)	2006-01-19	4,5-disubstituierte 2-aminopyrimidine
NO870241L (no)	1987-03-20	Hypoglykemiske tiazolidindioner.
ATE86491T1 (de)	1993-03-15	Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
BR0016013A (pt)	2003-02-25	Fibras aglutinantes hidrofìlicas biodegradáveis
TW237452B (de)	1995-01-01
DE69938791D1 (de)	2008-07-03	Orale methylphenidat-formulierungen mit kontrollierter/veränderter freisetzung
ATE272987T1 (de)	2004-08-15	Gerät zur behandlung von wachsenden, erweiterten oder missgebildeten blutgefässen
ATE248837T1 (de)	2003-09-15	Chinuclidin-acrylamide
DE60027728D1 (de)	2006-06-08	Stabile medizinische zusammensetzungen zur oralen verabreichung unter verwendung von eisenoxiden
ATE104853T1 (de)	1994-05-15	Verwendung des 6-((3-(4-(2-methoxyphenyl)-1piperazinyl>propyl>amino>-1,3-dimethyluracils zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von harnwegsverstopfungen.
IL86862A (en)	1993-05-13	Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna
ATE191849T1 (de)	2000-05-15	Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
ES2160649T3 (es)	2001-11-16	Nuevos compuestos lactamicos y procedimientos para su preparacion.
DE60108626D1 (de)	2005-03-03	Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
LV12251A (lv)	1999-04-20	2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai
KR960014108A (ko)	1996-05-22	퀴녹살린, 이의 제조방법 및 이의 용도
ATE188693T1 (de)	2000-01-15	2-(4-(4-azolylbutyl)-1-piperazinyl)-5- hydroxypyrimidin-derivate, deren herstellung und deren verwendung als heilmittel
NO20003629L (no)	2000-09-15	Forbindelser med veksthormonfrigjørende egenskaper
ATA67688A (de)	1993-06-15	Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren
FR2642758B1 (fr)	1991-05-17	Derives de pyrimidine,2-(4-((alpha)-heteroaryl-(alpha) aryl-((alpha)-alkyl)-methoxy)-butyl)-1-piperazinyl), avec activite serotoninergique
DE59107970D1 (de)	1996-08-08	3-(Mercaptoalkyl)-chinazolin-2,4(1H,3H)-dione, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen
ATE245621T1 (de)	2003-08-15	(+)- und (-)-2-cyclododecylpropanol und (+)- und (-)-2-cyclododecylpropionsäure sowie deren herstellung und verwendung
DE3874978D1 (de)	1992-11-05	Ponalrestat enthaltendes hyperurikaemie-mittel.
UA30339A (uk)	2000-11-15	Засіб "фурадонін" для лікування захворювань сечовивідної системи

Legal Events

Date	Code	Title
1995-01-15	UEP	Publication of translation of european patent specification
2002-06-15	REN	Ceased due to non-payment of the annual fee
2002-11-15	RZN	Patent revoked